CTRL+K
QUAGLIA LABORATORIO DE ANALISES CLINICAS LTDA.
Sociedade Empresária Limitada (206-2)
R$ 9,980,000.00
Actual or Presumed Profit
Partners and Administrators
3
1
0
| member |
|---|
Sócio – 11/14/2023 Administrador: Lidia Freire Abdalla Nery |
Offices
16
0
5
| CNPJ | Status | Alias | Founded | Main Activity |
|---|---|---|---|---|
| 45.697.141/0001-43 | Ativa | Sabin Diagnostico e Saude | 7/23/1974 | 8640-2/02 |
| 45.697.141/0002-24 | Ativa | Sabin Diagnostico e Saude | 11/28/1986 | 8640-2/02 |
| 45.697.141/0003-05 | Ativa | Sabin Diagnostico e Saude | 2/25/2008 | 8640-2/02 |
| 45.697.141/0004-96 | Baixada | - | 11/28/2008 | 8640-2/02 |
| 45.697.141/0005-77 | Ativa | Sabin Diagnostico e Saude | 5/22/1998 | 8640-2/02 |
| 45.697.141/0006-58 | Ativa | Sabin Diagnostico e Saude | 1/19/2005 | 8640-2/02 |
| 45.697.141/0007-39 | Baixada | Quaglia - Grupo Sabin | 5/21/2010 | 8640-2/02 |
| 45.697.141/0008-10 | Baixada | Quaglia Laboratorio de Analises Clinicas | 5/21/2010 | 8640-2/02 |
| 45.697.141/0009-09 | Baixada | Quaglia - Grupo Sabin | 5/21/2010 | 8640-2/02 |
| 45.697.141/0010-34 | Ativa | Sabin Diagnostico e Saude | 8/31/2011 | 8640-2/02 |
| 45.697.141/0011-15 | Ativa | Sabin Diagnostico e Saude | 10/7/2010 | 8640-2/02 |
| 45.697.141/0012-04 | Ativa | Sabin Diagnostico e Saude | 9/24/2015 | 8640-2/02 |
| 45.697.141/0013-87 | Ativa | Sabin Diagnostico e Saude | 9/24/2015 | 8640-2/02 |
| 45.697.141/0014-68 | Ativa | Sabin Diagnostico e Saude | 9/24/2015 | 8640-2/02 |
| 45.697.141/0015-49 | Ativa | Sabin Diagnostico e Saude | 9/24/2015 | 8640-2/02 |
| 45.697.141/0016-20 | Ativa | Sabin Diagnostico e Saude | 3/29/2016 | 8640-2/02 |
| 45.697.141/0017-00 | Ativa | Sabin Diagnostico e Saude | 9/9/2016 | 8640-2/02 |
| 45.697.141/0018-91 | Ativa | Sabin Diagnostico e Saude | 3/15/2019 | 8640-2/02 |
| 45.697.141/0019-72 | Baixada | Sabin Medicina Diagnostica | 3/15/2019 | 8640-2/02 |
| 45.697.141/0020-06 | Ativa | Sabin Diagnostico e Saude | 1/25/2022 | 8640-2/02 |
| 45.697.141/0021-97 | Ativa | Sabin Diagnostico e Saude | 2/3/2023 | 8640-2/02 |